| Abstrakt: |
A report from Peking University First Hospital in Beijing, China, discusses the prevalence of skin problems associated with insulin pump therapy in children with type 1 diabetes mellitus. The study found that 66.8% of the 461 children surveyed reported skin problems, including pigmentation changes, allergy/dermatitis, scarring, pain, infection, subcutaneous lipohypertrophy, and lipoatrophy. Factors associated with skin problems included the caregiver's educational level, the patient having skin allergies, and the use of a specific brand of insulin pump. The researchers suggest that health education should address these factors in addition to the traditionally emphasized ones. [Extracted from the article] |
